Entotherapy is a unique proprietary drug delivery platform. This revolutionary technology is in the process of being beta tested in glioblastoma patients. Entotherapy is an image-guided drug-eluting microcylinder platform whose origins date to the absorbable sutures of the 1970s. Biopolymers used to form absorbable sutures are non-toxic. Microspherix leveraged this biocompatibility to solve oncology’s failed efforts in targeted drug delivery. >> READ MORE
About EntoTherapy About Microspherix LL Entotheraphy